Atinary Technologies, whose leading no-code AI platform, SDLabsTM, and Self-Driving LabsTM technology are transforming research and development (R&D) of new molecules and chemicals, is thrilled to announce a strategic collaboration with Snapdragon Chemistry, a Cambrex company. Snapdragon is a recognized leader in active pharmaceutical ingredient (API) process development, with specialization in continuous flow process development, lab automation and complex synthetic APIs.
Through this collaboration, Snapdragon integrated its proprietary LabOSTM software platform with Atinary’s SDLabsTM platform to build a fully-automated and AI-driven, medium-throughput Solid-Phase Oligonucleotide Synthesizer (SPOS) for the purpose of autonomous multi-objective process optimizations. By using Atinary’s AI platform, Snapdragon’s process optimization campaign has demonstrated significant improvements across the tested applications, with up to an 18% increase in product yield and a 22% reduction in cost compared to processes previously optimized by an experienced scientist.
